Vaccine Scheduler
Luxembourg: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 3 | 4 | 5 | 11 | 12 | 13 | 15-23 | 5-6 | 9 | 12 | 14 | 15 | 16 | 17 | 18 | 20 | 64 | ≥ 65 | ||||
| Coronavirus disease (COVID-19) | COVID-191 | |||||||||||||||||||||
| rotavirus infection | ROTA | ROTA | ROTA | |||||||||||||||||||
| diphtheria | D | D2 | D | D | D | d3 | ||||||||||||||||
| tetanus | TT | TT2 | TT | TT | TT | TT3 | ||||||||||||||||
| pertussis | acP | acP2 | acP | acP | acP | acP4 | acp5 | |||||||||||||||
| poliomyelitis | IPV | IPV2 | IPV | IPV | IPV | IPV3 | ||||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib2 | Hib | Hib | ||||||||||||||||||
| hepatitis B | HepB6 | HepB | HepB2 | HepB | HepB7 | |||||||||||||||||
| pneumococcal disease | PCV | PCV2 | PCV | PCV | PCV8 | PCV9 | PCV10 | |||||||||||||||
| meningococcal disease | MenB | MenB | MenB | MCV4 | MCV4 | |||||||||||||||||
| measles | MEAS | MEAS | ||||||||||||||||||||
| mumps | MUMPS | MUMPS | ||||||||||||||||||||
| rubella | RUBE | RUBE | ||||||||||||||||||||
| varicella | VAR | VAR | ||||||||||||||||||||
| human papillomavirus infection | HPV9 (F/M) | HPV9 (F/M) | ||||||||||||||||||||
| influenza | IIV4 | |||||||||||||||||||||
| herpes zoster | ZOS11 | ZOS12 | ||||||||||||||||||||
Version:
Footnotes:
- for latest information refer to https://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/covid-19.html
- For premature infants (born before 33 weeks) or with a birthweight <1500g, a 3+1 schedule is recommended
- Subsequent Tdacp-IPV booster every 10 years
- One booster dose of Tdacp-IPV in this age group.
- One booster dose every 10 years. Vaccination for pregnant women between 13-26 weeks gestation - Tdap or TdapIPV vaccine
- Babies born to a mother infected with hepatitis B will be offered a dose at birth simultaneously with HB immunoglobulin
- if no history of vaccination
- For those not previously vaccinated with an increased risk of severe disease.
- for those at increased risk of complications or severe disease
- For people aged 65 years of age, update to the pneumococcal recommendations based on prior vaccination. please refer to the full recommendation available here: https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
- for immunosuppressed or ahead of period of immunosuppression. 2 doses 1-2 months apart.
- 2 doses 6-8 months apart
More information available at:
https://sante.public.lu/fr/espace-citoyen/dossiers-thematiques/v/vaccination/calendrier-vaccinal.html https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/schema-vaccinal/schema-vaccinal-2024-dtperpoliohib.pdf
-------------------------------------------------------------------------------------------------------------------------
ADDITIONAL COMMENT
All infant vaccinations in Luxembourg are given free of charge. All subsequent adult vaccinations are not free of charge.
MAJOR HISTORICAL CHANGES
1986: The combined MMR vaccine was introduced in the national childhood vaccination schedule and recommended at 15-18 months of age
1994: The second MMR dose was introduced in the national childhood vaccination schedule and recommended at 5-7 years
2008: March 2008. HPV vaccination was introduced in the national childhood vaccination schedule for females aged 12 years with a catch-up programme up to 18 years of age
2018: MenC 2nd dose introduced at 15-16 years; MenB introduced for increased risk groups
2022: Update to the pneumococcal vaccination policy. use of PCV20. refer to https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
2023: MCV4 introduced in the programme. can be proposed to >16 years if at increased risk of infection
2024: revised scheme for primary infant vaccination moving to a 2+1 schedule
Date of last update: 15 April 2024.
-------------------------------------------------------------------------------------------------------------------------